Is this you? Create Your Porfile
Avatar

Jonathan Mark Sutton

Chiesi Farmaceutici S.p.A.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jonathan Mark Sutton is active.

Explore More

Publication

Featured researches published by Jonathan Mark Sutton.

Archive | 2008

Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators

Lilian Alcaraz; Nicholas Kindon; Jonathan Mark Sutton

Archive | 2008

Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors

Jonathan Mark Sutton; Fabien Roussel; Den Heuvel Marco Van; Nicholas Charles Ray; Lilian Alcaraz

Archive | 2008

Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated

Lilian Alcaraz; Nicholas Kindon; Jonathan Mark Sutton

Archive | 2004

Substituted thienyl-hydroxamic acids having histone deacetylase activity

Hazel Joan Dyke; Stephen Price; Den Heuvel Marco Van; Jonathan Mark Sutton; Robert Edward Mackenzie; Robert Heald

Archive | 2013

Inhibition of enzymes

Carmelida Capaldi; Robert Andrew Heald; Nicholas Charles Ray; Jonathan Mark Sutton

Archive | 2012

Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors

Toby Jonathan Blench; Christine Edwards; Robert Andrew Heald; Janusz Kulagowski; Jonathan Mark Sutton; Carmelida Capaldi

Archive | 2010

Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

David Donald; Andrew Stephen Robert Jennings; Nicholas Charles Ray; Fabien Roussel; Jonathan Mark Sutton; Patrizia Tisselli; Michelle Wilson

Archive | 2017

inibição de enzimas

Carmelida Capaldi; Jonathan Mark Sutton; Nicholas Charles Ray; Robert Heald

Archive | 2017

DERIVADOS DE IMIDAZOLONA INHIBIDORES DE ELASTASAS DE NEUTRÓFILOS HUMANOS

Andrea Rizzi; Robert Heald; Jonathan Mark Sutton; Carmelida Capaldi; Elisabetta Armani

Archive | 2016

DERIVADOS DE PIRIMIDINONA

Lilian Alcaraz; Jonathan Mark Sutton; Elisabetta Armani; Carmelida Capaldi

Explore More

Collaboration

Dive into the Jonathan Mark Sutton's collaboration.

Top Co-Authors
Avatar

Carmelida Capaldi

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors
Avatar

Robert Heald

University of Arizona

View shared research outputs
Top Co-Authors
Avatar

Lilian Alcaraz

Loughborough University

View shared research outputs
Top Co-Authors
Avatar

Elisabetta Armani

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors
Avatar

Nicholas Kindon

Loughborough University

View shared research outputs
Top Co-Authors
Avatar

Nicholas Charles Ray

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Robert Andrew Heald

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors
Avatar

David Donald

Loughborough University

View shared research outputs
Top Co-Authors
Avatar

Fabien Roussel

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

Patrizia Tisselli

Janssen Pharmaceutica

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge